Cushman & Wakefield Grows its Capital Advisory business in Greater China and Australia
HONG KONG SAR - Media OutReach - 28 June 2023 - Cushman & Wakefield is…
3 years ago
AstraZeneca announces $400 million investment in reforestation and biodiversity in support of climate action and human health
Expansion of AZ Forest programme raises commitment to plant 200 million trees across six continents…
3 years ago
Nidec Files a Civil Action and a Complaint against Toyo Keizai Inc. and Former Employee, etc.
KYOTO, Japan--(BUSINESS WIRE)--Nidec Corporation (TOKYO: 6594) (OTC US: NJDCY) (“Nidec†or the “Companyâ€) announced today…
3 years ago
Black & Veatch Appoints Industry Veteran as President, Asia-Pacific and India as Company Continues Growth Across the Regions
Narsingh Chaudhary to succeed Hoe Wai Cheong who will retire at the end of 2023…
3 years ago
BBH Greater China ETF Investor Survey: Greater China ETF Market Grows as Product Platform Expands and Investors Evolve Usage
The number of investors with more than 25% of their portfolio invested in ETFs is…
3 years ago
The University of Hong Kong hosts APRU Presidents’ Meeting on Sustainable Future Solutions
HONG KONG SAR - Media OutReach - 28 June 2023 - The University of Hong…
3 years ago
Enish and GeekOut, two brands engaged in game app development and operation, announce the launch of their original Verse on Oasys and the release of “De:Lithe Last Memories as the first installment of this Verse.
SINGAPORE - Media OutReach - 28 June 2023 - Oasys, a gaming-optimised blockchain, is excited…
3 years ago
Navigator and Fullerton Fund Management Launch Collaboration to Expand Range of Investment Solutions
SINGAPORE - Media OutReach - 28 June 2023 - Navigator Investment Services Ltd ("Navigator"), an…
3 years ago
KLab Inc.’s Subsidiary BLOCKSMITH&Co. Announces Development of BLQS Verse and Adoption of user-contributed short vertical video quiz application “QAQA” on Oasys
TOKYO, JAPAN - Media OutReach - 28 June 2023 - KLab Inc. (Head office: Minato-ku,…
3 years ago
Microba Commences Phase I Clinical Trial for IBD Therapeutic
First participants have been successfully dosed in a Phase I Clinical Trial of MAP 315,…
3 years ago